مباشر

Clinical OMICsMayo Clinic’s REDMOD AI Doubles Early Detection Sensitivity in Pancreatic Cancer FierceBiotechIpsen scuttles liver disease candidates from $952M Albireo acquisition Endpoints NewsAmgen, AbbVie say IRA negotiations impacted Q1 sales Clinical OMICsAt-Home Blood Test Screens for Early Dementia Clinical OMICsGlioblastoma: Testosterone Supplements Linked to 38% Lower Risk of Death Endpoints NewsLilly plans new $4.5B manufacturing investment in Indiana Endpoints NewsBeOne culls five cancer programs and an autoimmune Phase 2 Endpoints NewsLonza looks to ride ADC wave with upcoming factory, workforce expansion FierceBiotechBipartisan PRIMATE Act aims to ban monkey imports to US Clinical OMICsEarly Glucagon Elevation Linked to MASLD in Type 2 Diabetes Clinical OMICsEpigenetic Markers Link Early-Onset Colon and Rectal Cancer to Specific Pesticide Clinical OMICsBlood Test Reads Cell Spatial Environment to Predict Immunotherapy Response

Clinical OMICs ٦ مايو ٢٠٢٦

Blood Test Reads Cell Spatial Environment to Predict Immunotherapy Response

Blood test results from plasma can predict which cancer patients will respond to immunotherapy—before treatment begins—by detecting conserved "spatial ecosystem...

Blood test results from plasma can predict which cancer patients will respond to immunotherapy—before treatment begins—by detecting conserved "spatial ecosystems" in the tumor microenvironment. The post Blood Test Reads Cell Spatial Environment to Predict Immunotherapy Response appeared first on Inside Precision Medicine .